41,809 Shares in First Trust Nasdaq Pharmaceuticals ETF $FTXH Purchased by Marshall Investment Management LLC

Marshall Investment Management LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the 4th quarter, HoldingsChannel reports. The firm acquired 41,809 shares of the company’s stock, valued at approximately $1,377,000. Marshall Investment Management LLC owned 0.06% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of FTXH. NBC Securities Inc. increased its position in First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after purchasing an additional 329 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth $57,000. Flagship Harbor Advisors LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter worth about $205,000. Stratos Wealth Partners LTD. acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth about $230,000. Finally, Vivaldi Capital Management LP increased its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 4.1% during the 3rd quarter. Vivaldi Capital Management LP now owns 9,790 shares of the company’s stock worth $279,000 after purchasing an additional 384 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ:FTXH opened at $34.87 on Tuesday. The business has a 50-day moving average price of $34.02 and a 200 day moving average price of $33.64. First Trust Nasdaq Pharmaceuticals ETF has a 12-month low of $24.86 and a 12-month high of $35.61. The company has a market capitalization of $31.38 million, a price-to-earnings ratio of 14.51 and a beta of 0.47.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Thursday, March 26th were paid a $0.0573 dividend. This represents a $0.23 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Thursday, March 26th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.